(Total Views: 480)
Posted On: 02/01/2022 12:20:53 PM
Post# of 153939
True, but also tells me the shorts are not shorting OR covering...waiting...hoping...feeling the anxiety of a potential Hyyuuuge catalyst.
Also suggests there are buyers willing to grab the low scraps
To offer in a valuation and buyouts...I think $10 is a pathetically low price, a steal attempt, and would hope the Board would reject it as would shareholders if offered a vote. I agree with Kelly's comment that CYDY will be an oncology company and that valuation has to be $50++ bare minimum. Plus NASH, HIV mono and who knows about potential Alzheimers and other diseases where the brain is involved. I think Covid treatment would be a nice cash flow but not the basis on which the company would be valued. (Did I cover all 29 on Ohms list?) I always felt $25 was a decent number to cash out, just on a personal note, although I feel $50 is very much in the cards and triple digits are a possibility (would need more time). But these are all exciting numbers. This is an exciting moment in CYDY's history.
To The Moon Alice
Also suggests there are buyers willing to grab the low scraps
To offer in a valuation and buyouts...I think $10 is a pathetically low price, a steal attempt, and would hope the Board would reject it as would shareholders if offered a vote. I agree with Kelly's comment that CYDY will be an oncology company and that valuation has to be $50++ bare minimum. Plus NASH, HIV mono and who knows about potential Alzheimers and other diseases where the brain is involved. I think Covid treatment would be a nice cash flow but not the basis on which the company would be valued. (Did I cover all 29 on Ohms list?) I always felt $25 was a decent number to cash out, just on a personal note, although I feel $50 is very much in the cards and triple digits are a possibility (would need more time). But these are all exciting numbers. This is an exciting moment in CYDY's history.
To The Moon Alice
(4)
(0)
